• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Farfetch Is Trading Higher By 32%, Here Are 46 Stocks Moving In Friday's Mid-Day Session

    8/26/22 12:52:30 PM ET
    $AFRM
    $AMTD
    $APGN
    $APWC
    Finance: Consumer Services
    Finance
    Finance: Consumer Services
    Finance
    Get the next $AFRM alert in real time by email

    Gainers

    • Micro Focus International plc (NYSE:MFGP) shares jumped 95.4% to $6.11 after the company reached an agreement with OpenText to be acquired for $6 billion.
    • The OLB Group, Inc. (NASDAQ:OLB) gained 47% to $1.73. OLB Group recently posted 1H sales of $17.16 million.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) shares rose 37.3% to $0.1867 after the company announced changes to its board of directors and management team, along with the launch of a review to explore the sale of the entire business or selected assets.
    • Farfetch Limited(NYSE:FTCH) rose 31.8% to $12.58 after reporting better-than-expected quarterly results.
    • NewAge, Inc. (NASDAQ:NBEV) rose 28.3% to $0.26 after declining around 7% on Thursday.
    • Green Giant Inc. (NASDAQ:GGE) gained 26% to $2.52.
    • Baudax Bio, Inc. (NASDAQ:BXRX) jumped 25.2% to $0.7018. Baudax Bio recently received Notice of Allowance for US patent application covering use of ANJESO for treatment of moderate to severe pain.
    • Akili, Inc. (NASDAQ:AKLI) shares gained 23.5% to $5.09 after dropping 20% on Thursday.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) gained 20.4% to $3.4779. Bright Minds recently priced overnight marketed offering of 2.858 million units at $1.40 per unit.
    • The L.S. Starrett Company (NYSE:SCX) jumped 15.1% to $8.73 after the company reported FY22 results.
    • CorpHousing Group Inc. (NASDAQ:CHG) gained 15% to $2.84. CorpHousing Group recently reported closing of $13.5 million initial public offering.
    • Pardes Biosciences, Inc. (NASDAQ:PRDS) jumped 12.8% to $3.7350. Pardes Biosciences recently posted a Q2 loss of $0.48 per share.
    • IDW Media Holdings, Inc. (NYSE:IDW) gained 12.6% to $1.8999. IDW Media recently named Allan Grafman as CEO.
    • Everbridge, Inc. (NASDAQ:EVBG) rose 12.1% to $40.09. Everbridge recently reported better-than-expected Q2 sales results and issued Q3 guidance above analyst estimates.
    • Apexigen, Inc. (NASDAQ:APGN) gained 10.7% to $5.48.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) jumped 9.7% to $29.92.
    • TAL Education Group (NYSE:TAL) rose 9.1% to $5.89.
    • Asia Pacific Wire & Cable Corporation Limited (NASDAQ:APWC) gained 8.6% to $1.77.
    • VTEX (NYSE:VTEX) shares rose 8.5% to $4.20. Vtex recently posted a Q2 loss of $0.11 per share.
    • Workday, Inc. (NASDAQ:WDAY) rose 6.3% to $172.53 after the company reported upbeat earnings for its second quarter. The company maintained full-year subscription revenue guidance between $5.537 billion and $5.557 billion.
    • Electronic Arts Inc. (NASDAQ:EA) gained 5.1% to $134.06 amid reports suggesting Amazon is set to buy the company. However, CNBC said Amazon is not expected to make a bid for Electronic Arts.
    • Ulta Beauty, Inc. (NASDAQ:ULTA) rose 2.8% to $430.82 as the company reported better-than-expected results for its second quarter and raised its FY22 guidance.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Domo, Inc. (NASDAQ:DOMO) shares dipped 28.7% to $20.45 after the company reported worse-than-expected Q2 sales results and issued Q3 and FY23 sales guidance below analyst estimates. Additionally, multiple analysts lowered their price target on the stock.
    • Mobilicom Limited (NASDAQ:MOB) fell 23.8% to $4.1684 on possible profit taking after the stock surged yesterday following its IPO debut.
    • Athersys, Inc. (NASDAQ:ATHX) shares fell 22.1% to $0.1361 after the company reported a 1-for-25 reverse stock split.
    • Vaccitech plc (NASDAQ:VACC) dropped 21.4% to $4.8686. The company recently posted a profit for the second quarter.
    • Lantronix, Inc. (NASDAQ:LTRX) fell 19.3% to $6.12 after the company posted downbeat Q4 earnings and issued weak earnings forecast for FY23.
    • Twin Vee Powercats Co. (NASDAQ:VEEE) fell 19.1% to $4.5049.
    • Starbox Group Holdings Ltd. (NASDAQ:STBX) dropped 18.4% to $5.78 on possible profit taking following Tuesday's IPO.
    • Tyra Biosciences, Inc. (NASDAQ:TYRA) declined 18% to $8.27.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) shares fell 17% to $25.91 after the company reported worse-than-expected Q4 EPS results and issued Q1 FY23 sales guidance below estimates.
    • Eargo, Inc. (NASDAQ:EAR) dropped 16% to $1.9300.
    • Vivakor, Inc. (NASDAQ:VIVK) fell 15.6% to $2.10.
    • Soleno Therapeutics, Inc. (NASDAQ:SLNO) declined 15.2% to $2.0615 following effect of 1:15 reverse stock split.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) dropped 15.1% to $31.69.
    • WeTrade Group, Inc. (NASDAQ:WETG) declined 12.3% to $1.84.
    • SunLink Health Systems, Inc. (NYSE:SSY) fell 12.3% to $1.57 after gaining 12% on Thursday.
    • Danimer Scientific, Inc. (NASDAQ:DNMR) fell 11.6% to $4.43. Danimer Scientific filed for mixed-securities shelf offering of up to $100 million.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) fell 11.1% to $1.5473. Streeterville Capital disclosed a 9.9% passive stake in the company.
    • REE Automotive Ltd. (NASDAQ:REE) dropped 10.7% to $1.1954. The company recently posted a Q2 loss.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) fell 9.8% to $0.2326. Kiora Pharmaceuticals shares jumped 95% on Thursday after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target of $6.50.
    • AMTD IDEA Group (NYSE:AMTD) fell 9.7% to $2.0852.
    • Dell Technologies Inc. (NYSE:DELL) fell 9.1% to $43.52. Dell Technologies reported upbeat earnings for its second quarter, while sales missed estimates.
    • Seagen Inc. (NASDAQ:SGEN) fell 8.5% to $150.44 after Bloomberg reported acquisition talks with Merck stalled over purchase price.
    • Carvana Co. (NYSE:CVNA) dropped 8.3% to $35.27.
    • Golden Ocean Group Limited (NASDAQ:GOGL) fell 5.6% to $10.26. Golden Ocean Group recently reported a second-quarter FY22 revenue increase of 14.9% year-over-year to $316.66 million.
    Get the next $AFRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFRM
    $AMTD
    $APGN
    $APWC

    CompanyDatePrice TargetRatingAnalyst
    Domo Inc.
    $DOMO
    2/13/2026$3.50Mkt Outperform → Mkt Underperform
    Citizens
    Tyra Biosciences Inc.
    $TYRA
    2/10/2026Outperform
    William Blair
    Affirm Holdings Inc.
    $AFRM
    2/3/2026$76.00Equal-Weight → Overweight
    Morgan Stanley
    TAL Education Group
    $TAL
    1/30/2026$18.00Neutral → Outperform
    Macquarie
    Tyra Biosciences Inc.
    $TYRA
    1/28/2026$59.00Overweight
    Barclays
    Affirm Holdings Inc.
    $AFRM
    1/27/2026$100.00Hold → Buy
    Needham
    Ulta Beauty Inc.
    $ULTA
    1/21/2026$790.00Outperform → Strong Buy
    Raymond James
    VTEX
    $VTEX
    1/15/2026$4.00Buy → Neutral
    UBS
    More analyst ratings

    $AFRM
    $AMTD
    $APGN
    $APWC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Anderson Robert Eugene Jr bought $24,940 worth of shares (8,600 units at $2.90) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/25/25 4:06:25 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Barry Richard bought $414,000 worth of shares (150,000 units at $2.76) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/24/25 4:02:17 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Barry Richard bought $201,809 worth of shares (73,385 units at $2.75) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/20/25 5:39:26 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFRM
    $AMTD
    $APGN
    $APWC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dell Technologies to Hold Conference Call Feb. 26 to Discuss Fourth Quarter and Full Fiscal 2026 Financial Results

    Dell Technologies (NYSE:DELL) will conduct a conference call Thursday, Feb. 26, 2026, at 3:30 p.m. CST to discuss its fiscal 2026 fourth quarter and full-year financial results. The conference will be available to the public as a live, audio-only webcast on Dell Technologies' website at investors.delltechnologies.com; an archived version will be available at the same location. The company will issue the results before the conference call broadcast via a press release with accompanying financial statements and guidance. At that time, the release, prepared remarks and a presentation containing additional financial and operating information with financial guidance may be downloaded from inve

    2/13/26 8:30:00 AM ET
    $DELL
    Computer Manufacturing
    Technology

    VTEX to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 26th, 2026

    VTEX (NYSE:VTEX), the backbone for connected commerce, will release the financial results for its fourth fiscal quarter and fiscal year ended December 31st, 2025, via conference call and audio webcast, on February 26th, 2026, at 4:30 pm Eastern Time. The conference call may be accessed by dialing +1-800-715-9871 (Conference ID –3544576–) and requesting inclusion in the call for VTEX. The live conference call can be accessed via audio webcast at the investor relations section of the Company's website at https://www.investors.vtex.com/. An archived webcast replay will be available following the call's conclusion. About VTEX VTEX (NYSE:VTEX) is the commerce suite of choice for bold CIOs

    2/11/26 4:01:00 PM ET
    $VTEX
    Computer Software: Prepackaged Software
    Technology

    Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET

    REDWOOD CITY, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will report its fourth quarter and full-year 2025 financial results, as well as operational highlights, after the close of the U.S. financial markets on Wednesday, February 25, 2026. The Company will host a conference call and webcast at 4:30 PM Eastern Time to discuss the results and provide an update on business operations. Conference Call Dial-In & Webcast Information Date:Wednesday, February 25, 2026Time:4:30 PM Eastern TimeUnited States:1-800-717-1738Internation

    2/11/26 8:00:00 AM ET
    $SLNO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AFRM
    $AMTD
    $APGN
    $APWC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Domo downgraded by Citizens with a new price target

    Citizens downgraded Domo from Mkt Outperform to Mkt Underperform and set a new price target of $3.50

    2/13/26 8:28:18 AM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    William Blair initiated coverage on Tyra Biosciences

    William Blair initiated coverage of Tyra Biosciences with a rating of Outperform

    2/10/26 8:03:00 AM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Affirm upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Affirm from Equal-Weight to Overweight and set a new price target of $76.00

    2/3/26 6:49:01 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    $AFRM
    $AMTD
    $APGN
    $APWC
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Tyra Biosciences Inc.

    SCHEDULE 13G - Tyra Biosciences, Inc. (0001863127) (Subject)

    2/13/26 4:30:02 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Tyra Biosciences Inc.

    SCHEDULE 13G/A - Tyra Biosciences, Inc. (0001863127) (Subject)

    2/13/26 4:15:02 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form POS AM filed by Twin Vee PowerCats Co.

    POS AM - Twin Vee PowerCats, Co. (0001855509) (Filer)

    2/13/26 6:09:06 AM ET
    $VEEE
    Marine Transportation
    Industrials

    $AFRM
    $AMTD
    $APGN
    $APWC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Discovery Officer Bensen Daniel sold $262,965 worth of shares (8,000 units at $32.87), decreasing direct ownership by 5% to 146,981 units (SEC Form 4)

    4 - Tyra Biosciences, Inc. (0001863127) (Issuer)

    2/13/26 4:30:07 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President, Special Projects Taira Thomas sold $417,271 worth of shares (1,047 units at $398.54), decreasing direct ownership by 2% to 66,625 units (SEC Form 4)

    4 - CARVANA CO. (0001690820) (Issuer)

    2/11/26 6:42:12 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Chief Operating Officer Linford Michael exercised 20,000 shares at a strike of $49.00, increasing direct ownership by 25% to 100,269 units (SEC Form 4)

    4 - Affirm Holdings, Inc. (0001820953) (Issuer)

    2/11/26 4:00:58 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    $AFRM
    $AMTD
    $APGN
    $APWC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Tyra Biosciences Inc.

    SC 13D/A - Tyra Biosciences, Inc. (0001863127) (Subject)

    12/6/24 9:30:49 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Twin Vee PowerCats Co.

    SC 13D/A - Twin Vee PowerCats, Co. (0001855509) (Subject)

    11/27/24 4:15:33 PM ET
    $VEEE
    Marine Transportation
    Industrials

    $AFRM
    $AMTD
    $APGN
    $APWC
    Financials

    Live finance-specific insights

    View All

    Dell Technologies to Hold Conference Call Feb. 26 to Discuss Fourth Quarter and Full Fiscal 2026 Financial Results

    Dell Technologies (NYSE:DELL) will conduct a conference call Thursday, Feb. 26, 2026, at 3:30 p.m. CST to discuss its fiscal 2026 fourth quarter and full-year financial results. The conference will be available to the public as a live, audio-only webcast on Dell Technologies' website at investors.delltechnologies.com; an archived version will be available at the same location. The company will issue the results before the conference call broadcast via a press release with accompanying financial statements and guidance. At that time, the release, prepared remarks and a presentation containing additional financial and operating information with financial guidance may be downloaded from inve

    2/13/26 8:30:00 AM ET
    $DELL
    Computer Manufacturing
    Technology

    VTEX to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 26th, 2026

    VTEX (NYSE:VTEX), the backbone for connected commerce, will release the financial results for its fourth fiscal quarter and fiscal year ended December 31st, 2025, via conference call and audio webcast, on February 26th, 2026, at 4:30 pm Eastern Time. The conference call may be accessed by dialing +1-800-715-9871 (Conference ID –3544576–) and requesting inclusion in the call for VTEX. The live conference call can be accessed via audio webcast at the investor relations section of the Company's website at https://www.investors.vtex.com/. An archived webcast replay will be available following the call's conclusion. About VTEX VTEX (NYSE:VTEX) is the commerce suite of choice for bold CIOs

    2/11/26 4:01:00 PM ET
    $VTEX
    Computer Software: Prepackaged Software
    Technology

    Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET

    REDWOOD CITY, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will report its fourth quarter and full-year 2025 financial results, as well as operational highlights, after the close of the U.S. financial markets on Wednesday, February 25, 2026. The Company will host a conference call and webcast at 4:30 PM Eastern Time to discuss the results and provide an update on business operations. Conference Call Dial-In & Webcast Information Date:Wednesday, February 25, 2026Time:4:30 PM Eastern TimeUnited States:1-800-717-1738Internation

    2/11/26 8:00:00 AM ET
    $SLNO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AFRM
    $AMTD
    $APGN
    $APWC
    Leadership Updates

    Live Leadership Updates

    View All

    Workday Announces CEO Transition as Co-Founder Aneel Bhusri Returns to Lead the Company's Next Chapter

    Carl Eschenbach Steps Down After Leading Company Through a Period of Global Expansion and Operational Scale Company Reaffirms Fiscal 2026 Fourth Quarter and Full-Year Outlook PLEASANTON, Calif., Feb. 9, 2026 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced that co-founder and current executive chair Aneel Bhusri is returning as chief executive officer as the company enters its next chapter, focused on leading in the rapidly evolving AI era. Carl Eschenbach is stepping down as CEO and as a member of the board after leading Workday through a period defined by global growth, an expanded industry focus, and strengthen

    2/9/26 8:30:00 AM ET
    $WDAY
    EDP Services
    Technology

    Corinex Appoints George Reznik as Chief Operating Officer to Accelerate Global Expansion

    VANCOUVER, BC, Feb. 2, 2026 /PRNewswire/ - Corinex, a global leader in Broadband-over-Power-Line (BPL) technology, announced the appointment of George Reznik as Chief Operating Officer. Mr. Reznik is an entrepreneurial, operational, and strategic executive leader. He has a track record of growing top-line revenue, bottom-line performance, and market share while building, commercializing, and scaling global technology companies.Corinex is accelerating the transformation of electricity networks, turning existing power line infrastructure into high-capacity, secure communications networks. This helps utilities accelerate grid modernization, integrate low-carbon technologies at scale, and increa

    2/2/26 12:30:00 PM ET
    $LTRX
    Computer Communications Equipment
    Telecommunications

    Workiva Announces Two New Appointments to Board of Directors

    Company Appoints Former Cisco and Autodesk CFO Scott Herren and Former Workday Co-President, CFO, and EVP Mark Peek Workiva Inc. (NYSE:WK), a leading, AI-powered platform for trust, transparency, and accountability, today announced the appointment of two new independent directors to its Board of Directors. Scott Herren is the former EVP and Chief Financial Officer of Cisco and current Board member and Audit Committee Chair at Rubrik (NYSE:RBRK). Mark Peek is a former EVP, CFO, and Co-President of Workday (NASDAQ:WDAY) and currently sits on the Board of Directors for SentinelOne (NYSE:S) and Trimble (NASDAQ:TRMB). "We are pleased to welcome two highly experienced SaaS leaders to our Boar

    1/28/26 4:05:00 PM ET
    $RBRK
    $S
    $TRMB
    Computer Software: Prepackaged Software
    Technology
    Industrial Machinery/Components
    Industrials